title: Advances in the treatment of diabetic nephropathy.
abstract: While renal and cardiovascular outcomes trials are required, several new therapies for patients with diabetes are promising. The diabetic nephropathy research community will hopefully continue to learn from recent experiences, through the step-wise design of clinical trials, including proof-of-principle and mechanistic studies, followed by investment in adequately powered clinical trials that will capture important renal and cardiovascular long-term outcomes.
authors: Division of Nephrology at Toronto General Hospital.
authors: David Z I
authors: DZ
authors: Cherney
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D011507:Proteinuria / Q000188:drug therapy*; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; C089180:SLC5A2 protein, human; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors